CompletedPhase 4

Human Ovarian Follicular Dynamics and Emergency Contraception

Canada40 participantsStarted 2005-07

Plain-language summary

The researchers hypothesize that emergency contraception (EC) will initiate the changes associated with atresia or ovulatory failure at all stages of follicular development and that the image attributes associated with atresia will be similar regardless of the diameter of the dominant follicle when ovarian suppression is initiated. Second, changes associated with atresia may be observed, but ovulation of the dominant follicle is unimpeded.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female volunteers of childbearing potential;
✓. Are first time users of oral contraception (OC) or have discontinued OC at least 1 month prior to study entry;
✓. Age between 18 and 40 years old;
✓. Normal body mass index (18-38);
✓. Has signed informed consent form; and
✓. Is in good health as confirmed by medical history, physical examination.

Exclusion criteria

✕. A positive pregnancy test will automatically exclude the volunteer from participation in this study.
✕. Any contraindication for oral contraception use;
✕. Irregular menstrual cycles;
✕. Ultrasonographic evidence of ovarian dysfunction, such as polycystic ovary syndrome (PCOS);
✕. Pregnancy (suspected or diagnosed) or lactation;
✕. History or suspicion of drug or alcohol abuse;
✕. Participation in an investigational drug trial within the 30 days prior to selection;
✕. Exhibits a disorder that is a contraindication to steroid hormonal therapy, including, for example, the following conditions:

What they're measuring

follicle development

ovulation status

peripheral blood pressure

Trial details

NCT IDNCT00204451

SponsorUniversity of Saskatchewan

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Contraception trials